Nichi-Iko Pharmaceutical employs advanced technologies and rigorous quality control systems to ensure the production of high-quality generic drugs. The company adheres to Good Manufacturing Practices (GMP) standards, which guide its manufacturing processes and quality assurance protocols. Each of its production facilities is designed to optimize the manufacturing of specific dosage forms, such as tablets, capsules, injections, and value-added products like oral jellies and eye drops. The integration and reorganization of production lines across various plants enhance the stability and safety of drug supply, while specialized facilities, such as the Honeycomb Building, focus on innovative formulation techniques that prioritize user experience and usability.

In its drug development process, Nichi-Iko emphasizes a comprehensive approach that includes patent searches, selection of drug substances, and extensive testing to ensure bioequivalence and stability. The company’s Development and Planning Department plays a crucial role in identifying marketable generic drug candidates, while the Product Test Department conducts rigorous quality assessments and bioequivalence studies. This systematic methodology not only accelerates the launch of generic drugs but also maintains a commitment to high standards of efficacy and safety, ultimately ensuring that patients receive reliable and effective medications.

Japan

Nichi-Iko Pharmaceutical is a pharmaceutical company that specializes in healthcare products and medicines.

Nichi-Iko Pharmaceutical

Company Details